Recent research (24) has demonstrated a strong link between the intensity of CRF and SNPs in the circadian rhythm genes PER2 and ARNTL2 among individuals with glioma, providing valuable insights into how circadian rhythm disruptions may exacerbate fatigue in cancer patients. Here, BMAL2 is linked to glioma.